Expanding the universe of new treatments for patients

Jennifer Petter, Arrakis Chief Scientific Officer, is Contributing Author in Feature on Women Scientists in Journal of Medicinal Chemistry

Waltham, Mass., March 8, 2024 – Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small molecule medicines that directly target RNA, today announced that the company’s Chief Scientific Officer, Jennifer Petter, PhD, has contributed to a feature on Women Scientists in the Journal of Medicinal Chemistry, published today. The publication, entitled “Empowering Voices: Inspiring Women in Medicinal Chemistry,” features female medicinal chemistry scientists who are recognized as role models and express their insights and motivations for conducting research in medicinal chemistry and improving human health. The feature article was published concurrent with International Women’s Day 2024.

“I am thrilled to be included in this collaborative group of women leaders who have come together to inspire the next generation of women scientists,” said Dr. Petter. “Drug discovery is a field that requires taking on challenges and risks, and seeing women role models is important for inspiring young female scientists to envision themselves on this career path where every brilliant mind will be needed to create the next generation of medicines.”

This feature in the Journal of Medicinal Chemistry is an initiative of the ACS Medicinal Chemistry Division (MEDI) in recognition of International Women’s Day 2024 to foster a sense of belonging, relevance, and empowerment by sharing uplifting stories of what inspired female medicinal chemists to pursue their scientific careers.

About Arrakis Therapeutics

Arrakis Therapeutics is a biopharmaceutical company pioneering the discovery of a new class of medicines that directly target RNA. Arrakis is building a proprietary pipeline of RNA-targeted small molecule (rSM) medicines focused on cancer and genetically validated targets in other disease areas. The company brings together scientific leaders in RNA structure, chemistry and biology, along with a highly experienced management team and the backing of leading life sciences investors. The company is located in Waltham, Massachusetts. For more information, please visit www.arrakistx.com and engage with us on Twitter @ArrakisTx or on LinkedIn.